3C-P: Difference between revisions
>Bindingaffinity add summary sheets |
>Bindingaffinity add a reference to Halberstadt, et al 2019 |
||
Line 22: | Line 22: | ||
3C-P's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive. | 3C-P's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive. | ||
According to the structure-activity-relationship between mescaline analogues, 3C-P has been identified as being more potent than [[mescaline]] and [[TMA-2]]. It has similar potency in animal studies to 3C-E, and the authors of one study on potency of mescaline analogues in rats predict that it may have similar effects and dosage to 3C-E.<ref>Halberstadt, AL; Chatha, M; Chapman, SJ; Brandt, SD. [https://bitnest.netfirms.com/external/10.1177/0269881119826610 Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.] ''J. Psychopharmacol.'', 21 Feb 2019, ''0269881119826610''. 901 kB. <nowiki>https://doi.org/10.1177/0269881119826610</nowiki></ref> | |||
==Subjective effects== | ==Subjective effects== |